المؤلفون: Mwesigwa N; Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (N.M., C.A.S.)., Shibao CA; Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (N.M., C.A.S.).

المصدر: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2024 Jul; Vol. 81 (7), pp. 1460-1466. Date of Electronic Publication: 2024 May 20.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Lippincott, Williams & Wilkins Country of Publication: United States NLM ID: 7906255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4563 (Electronic) Linking ISSN: 0194911X NLM ISO Abbreviation: Hypertension Subsets: MEDLINE

مواضيع طبية MeSH: Hypotension, Orthostatic*/drug therapy , Hypotension, Orthostatic*/physiopathology , Adrenergic Uptake Inhibitors*/therapeutic use , Adrenergic Uptake Inhibitors*/pharmacology , Norepinephrine* , Atomoxetine Hydrochloride*/therapeutic use , Atomoxetine Hydrochloride*/pharmacology, Humans ; Norepinephrine Plasma Membrane Transport Proteins/antagonists & inhibitors ; Norepinephrine Plasma Membrane Transport Proteins/metabolism ; Blood Pressure/drug effects ; Blood Pressure/physiology

المؤلفون: Kher JD; Research Scholar, Faculty of Pharmacy, Dharmsinh Desai University, Nadiad, Gujarat, India.; Assistant Professor, Department of Pharmacology, Laxminarayan Dev College of Pharmacy, Bharuch, Gujarat, India., Sorathia K; Assistant Professor, Department of Pharmaceutics, Faculty of Pharmacy, Dharmsinh Desai University, Nadiad, Gujarat, India.

المصدر: Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology [Zhongguo Ying Yong Sheng Li Xue Za Zhi] 2024 Jun 12; Vol. 40, pp. e20240002. Date of Electronic Publication: 2024 Jun 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Zhongguo ying yong sheng li xue za zhi bian ji bu Country of Publication: China NLM ID: 9426407 Publication Model: Electronic Cited Medium: Print ISSN: 1000-6834 (Print) Linking ISSN: 10006834 NLM ISO Abbreviation: Zhongguo Ying Yong Sheng Li Xue Za Zhi Subsets: MEDLINE

مواضيع طبية MeSH: Raloxifene Hydrochloride*/chemistry , Raloxifene Hydrochloride*/pharmacokinetics , Biological Availability* , Solubility* , beta-Cyclodextrins*/chemistry, Animals ; Poloxamer/chemistry ; Drug Carriers/chemistry

المؤلفون: Kazimir A; new address, Institute for Drug Discovery, Leipzig University, Leipzig, Brüderstraße 34, 04103, Germany.; Faculty of Chemistry and Mineralogy, Leipzig University, Johannisallee 29, Leipzig, 04103, Germany., Götze T; Faculty of Chemistry and Mineralogy, Leipzig University, Johannisallee 29, Leipzig, 04103, Germany., Lönnecke P; Faculty of Chemistry and Mineralogy, Leipzig University, Johannisallee 29, Leipzig, 04103, Germany., Murganić B; Institute of Nuclear Sciences 'Vinča', University of Belgrade, 12-14 Mike Petrovića Street, Belgrade, 11351, Serbia., Mijatović S; Department of Immunology, Institute for Biological Research 'Siniša Stanković', National Institute of Republic of Serbia, Belgrade University, Bul. despota Stefana 142, Belgrade, 11060, Serbia., Maksimović-Ivanić D; Department of Immunology, Institute for Biological Research 'Siniša Stanković', National Institute of Republic of Serbia, Belgrade University, Bul. despota Stefana 142, Belgrade, 11060, Serbia., Hey-Hawkins E; Faculty of Chemistry and Mineralogy, Leipzig University, Johannisallee 29, Leipzig, 04103, Germany.

المصدر: ChemMedChem [ChemMedChem] 2024 Jul 15; Vol. 19 (14), pp. e202400006. Date of Electronic Publication: 2024 Jun 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101259013 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-7187 (Electronic) Linking ISSN: 18607179 NLM ISO Abbreviation: ChemMedChem Subsets: MEDLINE

مواضيع طبية MeSH: Palladium*/chemistry , Palladium*/pharmacology , Nickel*/chemistry , Nickel*/pharmacology , Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/pathology , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemistry , Antineoplastic Agents*/chemical synthesis , Platinum*/chemistry , Platinum*/pharmacology , Coordination Complexes*/chemistry , Coordination Complexes*/pharmacology , Coordination Complexes*/chemical synthesis , Cell Proliferation*/drug effects , Raloxifene Hydrochloride*/chemistry , Raloxifene Hydrochloride*/pharmacology , Drug Screening Assays, Antitumor*, Humans ; Cell Line, Tumor ; Structure-Activity Relationship ; Molecular Structure ; Dose-Response Relationship, Drug ; Female

المؤلفون: Yang W; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Mental Health Center, Hangzhou, Zhejiang, People's Republic of China., Hu D; Department of pharmacy, ZheJiang Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China., Zheng B; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China., Han B; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China., Feng P; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China., Zhou Y; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Mental Health Center, Hangzhou, Zhejiang, People's Republic of China.; Department of Psychiatry, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China., Wang W; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China.; Zhejiang Mental Health Center, Hangzhou, Zhejiang, People's Republic of China.; Department of Psychiatry, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China., Li G; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China. ligonghua88@163.com.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China. ligonghua88@163.com., Zhang M; Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China. zml9998@sina.com.; Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China. zml9998@sina.com.

المصدر: BMC psychiatry [BMC Psychiatry] 2024 Jul 08; Vol. 24 (1), pp. 491. Date of Electronic Publication: 2024 Jul 08.

نوع المنشور: Journal Article; Case Reports; Review

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE

مواضيع طبية MeSH: Lurasidone Hydrochloride*/adverse effects , Lurasidone Hydrochloride*/therapeutic use , Bipolar Disorder*/drug therapy , Antipsychotic Agents*/adverse effects , Antipsychotic Agents*/therapeutic use , Exanthema*/chemically induced, Humans ; Male ; Middle Aged ; East Asian People

المؤلفون: Aghili M; Cancer Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran. aghili@tums.ac.ir.; Radiation Oncology Department, Cancer Institute, Imam-Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran. aghili@tums.ac.ir., Taherioun M; Radiation Oncology Department, Cancer Institute, Imam-Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Jafari F; Radiation Oncology Department, Cancer Institute, Imam-Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.; Gamma-Knife Center, Yas Hospital, Tehran University of Medical Sciences, Tehran, Iran.; Radiation Oncology Research Center (RORC), Imam Khomeini Hospital Complex, Tehran, Iran., Azadvari M; Physical Medicine & Rehabilitation Department, Imam-Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Lashkari M; Radiation Oncology Research Center (RORC), Imam Khomeini Hospital Complex, Tehran, Iran., Kolahdouzan K; Radiation Oncology Department, Cancer Institute, Imam-Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Ghalehtaki R; Radiation Oncology Research Center (RORC), Imam Khomeini Hospital Complex, Tehran, Iran., Abdshah A; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Jul 08; Vol. 32 (8), pp. 493. Date of Electronic Publication: 2024 Jul 08.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Duloxetine Hydrochloride*/administration & dosage , Duloxetine Hydrochloride*/therapeutic use , Paclitaxel*/adverse effects , Paclitaxel*/administration & dosage , Breast Neoplasms*/drug therapy , Peripheral Nervous System Diseases*/chemically induced , Peripheral Nervous System Diseases*/prevention & control , Antineoplastic Agents, Phytogenic*/adverse effects , Antineoplastic Agents, Phytogenic*/administration & dosage, Humans ; Female ; Double-Blind Method ; Middle Aged ; Adult ; Quality of Life ; Aged

المؤلفون: Guo L; College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China. jianbotong@aliyun.com.; Shaanxi Key Laboratory of Chemical Additives for Industry, Xi'an 710021, China., Chang Z; College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China. jianbotong@aliyun.com.; Shaanxi Key Laboratory of Chemical Additives for Industry, Xi'an 710021, China., Tong J; College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China. jianbotong@aliyun.com.; Shaanxi Key Laboratory of Chemical Additives for Industry, Xi'an 710021, China., Gao P; College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China. jianbotong@aliyun.com.; Shaanxi Key Laboratory of Chemical Additives for Industry, Xi'an 710021, China., Zhang Y; College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China. jianbotong@aliyun.com.; Shaanxi Key Laboratory of Chemical Additives for Industry, Xi'an 710021, China., Liu Y; College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China. jianbotong@aliyun.com.; Shaanxi Key Laboratory of Chemical Additives for Industry, Xi'an 710021, China., Yang Y; College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China. jianbotong@aliyun.com.; Shaanxi Key Laboratory of Chemical Additives for Industry, Xi'an 710021, China., Wang C; College of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China. jianbotong@aliyun.com.; Shaanxi Key Laboratory of Chemical Additives for Industry, Xi'an 710021, China.

المصدر: Physical chemistry chemical physics : PCCP [Phys Chem Chem Phys] 2024 Jul 03; Vol. 26 (26), pp. 18149-18161. Date of Electronic Publication: 2024 Jul 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 100888160 Publication Model: Electronic Cited Medium: Internet ISSN: 1463-9084 (Electronic) Linking ISSN: 14639076 NLM ISO Abbreviation: Phys Chem Chem Phys Subsets: MEDLINE

مواضيع طبية MeSH: Quantitative Structure-Activity Relationship* , Donepezil*/chemistry , Donepezil*/pharmacology , Cholinesterase Inhibitors*/chemistry , Cholinesterase Inhibitors*/pharmacology , Molecular Dynamics Simulation* , Molecular Docking Simulation* , Acetylcholinesterase*/metabolism , Acetylcholinesterase*/chemistry , Vilazodone Hydrochloride*/chemistry , Vilazodone Hydrochloride*/pharmacology , Drug Design*, Humans

المؤلفون: Aye PS; Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand., Barnes J; School of Pharmacy, University of Auckland, Auckland, New Zealand., Laking G; Te Aka Mātauranga Matepukupuku Centre for Cancer Research, University of Auckland, Auckland, New Zealand., Cameron L; Department of Medical Oncology, Te Pūriri o Te Ora Regional Cancer and Blood Service, Te Whatu Ora Health New Zealand, Auckland City Hospital, Auckland, New Zealand., Anderson M; Department of Medical Oncology, Te Whatu Ora Health New Zealand Te Pae Hauuora o Ruahine o Tararua, Palmerston North Hospital, Palmerston North, New Zealand., Luey B; Wellington Blood and Cancer Centre, Te Whatu Ora Health New Zealand Capital, Coast and Hutt Valley, Wellington Hospital, Wellington, New Zealand., Delany S; Department of Oncology, Te Whatu Ora Health New Zealand Nelson Marlborough, Nelson Hospital, Nelson, New Zealand., Harris D; Oncology Service, Te Whatu Ora - Waitaha Canterbury, Christchurch Hospital, Christchurch, New Zealand., McLaren B; Southern Blood and Cancer Service, Te Whatu Ora Southern, Dunedin Hospital, Dunedin, New Zealand., Brenman E; Cancer and Haematology Services, Te Whatu Ora Health New Zealand Haora a Toi Bay of Plenty, Tauranga Hospital, Tauranga, New Zealand., Wong J; Cancer Services, Te Whatu Ora Health New Zealand Waikato, Waikato Hospital, Hamilton, New Zealand., Lawrenson R; Medical Research Centre, University of Waikato, Hamilton, New Zealand., Arendse M; Department of Pathology, Te Whatu Ora Health New Zealand Waikato, Waikato Hospital, Hamilton, New Zealand., Tin Tin S; Department of Epidemiology and Biostatistics, University of Auckland, Auckland, New Zealand., Elwood M; Department of Epidemiology and Biostatistics, University of Auckland, Auckland, New Zealand., Hope P; Lung Foundation New Zealand, Manukau, Auckland, New Zealand., McKeage MJ; Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand.; Department of Medical Oncology, Te Pūriri o Te Ora Regional Cancer and Blood Service, Te Whatu Ora Health New Zealand, Auckland City Hospital, Auckland, New Zealand.; Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand.

المصدر: JMIR research protocols [JMIR Res Protoc] 2024 Jul 02; Vol. 13, pp. e51381. Date of Electronic Publication: 2024 Jul 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101599504 Publication Model: Electronic Cited Medium: Internet ISSN: 1929-0748 (Electronic) Linking ISSN: 19290748 NLM ISO Abbreviation: JMIR Res Protoc Subsets: MEDLINE

مواضيع طبية MeSH: Erlotinib Hydrochloride*/therapeutic use , Erlotinib Hydrochloride*/adverse effects , Gefitinib*/therapeutic use , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/mortality , ErbB Receptors*/genetics , ErbB Receptors*/antagonists & inhibitors , Mutation*, Humans ; Retrospective Studies ; New Zealand ; Female ; Male ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/adverse effects ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/adverse effects ; Cohort Studies ; Middle Aged ; Aged

المؤلفون: Alhubaishi AA; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Alsharekh LM; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Almoharb HF; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Alqarni FA; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Alqahtani AM; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Alghazwni MK; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Alfuraydi MA; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Alsadi AZ; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Altalhi RY; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Almutairi TM; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Alshehri GH; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia.

المصدر: Neurosciences (Riyadh, Saudi Arabia) [Neurosciences (Riyadh)] 2024 Jul; Vol. 29 (3), pp. 184-189.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Armed Forces Hospital Country of Publication: Saudi Arabia NLM ID: 101252453 Publication Model: Print Cited Medium: Internet ISSN: 1319-6138 (Print) Linking ISSN: 13196138 NLM ISO Abbreviation: Neurosciences (Riyadh) Subsets: MEDLINE

مواضيع طبية MeSH: Fingolimod Hydrochloride*/therapeutic use , Fingolimod Hydrochloride*/adverse effects , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/adverse effects , Patient Safety* , Multiple Sclerosis*/drug therapy, Humans ; Female ; Male ; Retrospective Studies ; Adult ; Middle Aged ; Guideline Adherence/statistics & numerical data

المؤلفون: Chan WM; Department of Pharmacy, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical, Foundation, New Taipei City, Taiwan, Republic of China., Wu TW, Peng TR

المصدر: American journal of therapeutics [Am J Ther] 2024 Jul-Aug 01; Vol. 31 (4), pp. e522.

نوع المنشور: Case Reports; Letter; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9441347 Publication Model: Print Cited Medium: Internet ISSN: 1536-3686 (Electronic) Linking ISSN: 10752765 NLM ISO Abbreviation: Am J Ther Subsets: MEDLINE

مواضيع طبية MeSH: Prasugrel Hydrochloride*/adverse effects , Prasugrel Hydrochloride*/therapeutic use , Platelet Aggregation Inhibitors*/adverse effects , Fever*/chemically induced , Fever*/drug therapy, Humans ; Male ; Middle Aged ; Drug Fever

المؤلفون: Bharadwaj S; Stanford University School of Medicine, Stanford, California, USA., Lau E; Stanford University School of Medicine, Stanford, California, USA., Hamilton MP; Stanford University School of Medicine, Stanford, California, USA., Goyal A; Stanford University School of Medicine, Stanford, California, USA., Srinagesh H; Stanford University School of Medicine, Stanford, California, USA., Jensen A; Stanford University School of Medicine, Stanford, California, USA., Lee D; Stanford University School of Medicine, Stanford, California, USA., Mallampet J; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, California, USA., Elkordy S; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, California, USA., Syal S; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, California, USA., Patil S; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, California, USA., Latchford T; Stanford University School of Medicine, Stanford, California, USA., Sahaf B; Cancer Institute, Stanford University School of Medicine, Palo Alto, California, USA., Arai S; Stanford University School of Medicine, Stanford, California, USA., Johnston LJ; Stanford University School of Medicine, Stanford, California, USA., Lowsky R; Stanford University School of Medicine, Stanford, California, USA., Negrin R; Stanford University, Stanford, California, USA., Rezvani AR; Stanford University School of Medicine, Stanford, California, USA., Shizuru J; Stanford Medicine, Palo Alto, California, USA., Meyer EH; Stanford University School of Medicine, Stanford, California, USA., Shiraz P; Stanford University School of Medicine, Stanford, California, USA., Mikkilineni L; Stanford University School of Medicine, Stanford, California, USA., Weng WK; Stanford University School of Medicine, Stanford, California, USA., Smith M; Stanford University School of Medicine, Stanford, California, USA., Sidana S; Stanford University School of Medicine, Stanford, California, USA., Muffly L; Stanford University, Palo Alto, California, USA., Maecker HT; Stanford University, Stanford, California, USA., Frank MJ; Stanford University School of Medicine, Stanford, California, USA., Mackall C; Stanford University, Stanford, California, USA., Miklos D; Stanford University, Stanford, California, USA., Dahiya S; Stanford University School of Medicine, Stanford, California, USA sdahiya@stanford.edu.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jul 01; Vol. 12 (7). Date of Electronic Publication: 2024 Jul 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Bendamustine Hydrochloride*/therapeutic use , Bendamustine Hydrochloride*/administration & dosage , Lymphoma, Large B-Cell, Diffuse*/drug therapy , Biological Products*/therapeutic use , Biological Products*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Immunotherapy, Adoptive/methods ; Immunotherapy, Adoptive/adverse effects ; Antigens, CD19/immunology ; Antigens, CD19/therapeutic use